8/6/2020 2:04:54 AM
GSK: FDA Approves BLENREP For Patients With Relapsed Or Refractory Multiple Myeloma
8/4/2020 6:17:30 AM
IDEAYA Announces HSR Clearance Of GSK Partnership In Synthetic Lethality
8/3/2020 2:36:28 AM
Sanofi, GSK In Advanced Talks With EU To Supply Up To 300 Mln Doses Of COVID-19 Vaccine
7/31/2020 8:34:33 AM
Sanofi, GSK Announce Collaborative Effort To Accelerate Development Of COVID-19 Vaccine
7/29/2020 7:04:25 AM
GlaxoSmithKline Q2 Total EPS 45.5p; Adj EPS 19.2p
7/29/2020 1:21:43 AM
Sanofi, GSK Agree With UK Government To Supply Up To 60 Mln Doses Of COVID-19 Vaccine
7/24/2020 8:43:01 AM
GSK Gets Positive CHMP Opinion For Belantamab Mafodotin For Relapsed And Refractory Multiple Myeloma
7/20/2020 2:03:42 AM
GSK To Make Equity Investment Of £130 Mln In CureVac
7/14/2020 5:48:01 PM
GlaxoSmithKline: FDA Advisory Committee Votes In Favour Of Positive Benefit/risk Profile For Belantamab Mafodotin